Lixin Wu
Hong Kong University of Science and Technology(HK)Peking University(CN)Peking University People's Hospital(CN)Peking University Shenzhen Hospital(CN)Heilongjiang Provincial Hospital(CN)University of Hong Kong - Shenzhen Hospital(CN)Shenzhen Children's Hospital(CN)Third People's Hospital of Hefei(CN)Guangdong Provincial People's Hospital(CN)First Affiliated Hospital of Zhengzhou University(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer-related molecular mechanisms research, RNA modifications and cancer, Acute Myeloid Leukemia Research, RNA Research and Splicing
Most-Cited Works
- → Sangerbox 2: Enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform(2024)88 cited
- → Writers, readers, and erasers RNA modifications and drug resistance in cancer(2024)77 cited
- → CAR T-cell therapy for triple-negative breast cancer: Where we are(2020)74 cited
- → FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis(2020)29 cited
- → Concurrent ROS1 gene rearrangement and KRAS mutation in lung adenocarcinoma: A case report and literature review(2017)29 cited
- → Ginsenoside compound K inhibits growth of lung cancer cells via HIF-1α-mediated glucose metabolism(2019)28 cited